How do policymaker perceptions of antimicrobial resistance drive behaviour and policies for appropriate antimicrobial use? A case study of Pakistan
How do policymaker perceptions of antimicrobial resistance drive behaviour and policies for appropriate antimicrobial use? A case study of Pakistan
批准号:
ES/P003842/1
负责人:
Johanna Hanefeld
金额:
$25.74万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The research proposed here is for a pump prime award to determine how policymakers' perceptions of Antimicrobial Resistance (AMR) drive their behaviour and selection of policy options aimed at appropriate use of antimicrobials, focusing on one lower middle income country: Pakistan. Applying qualitative methods and engaging a multidisciplinary team with human and animal health expertise, it will map policy actors and their networks, drawing on the Social Construction Framework, to identify how motivation, social constructions, power relations and contextual factors shape policy maker behaviour. Research findings will be essential to achieving the ESRC's underlying objective to identify the specific economic factors, cultural norms, experiences and practices relating to antibiotics that enable the best strategies for action, by providing concrete knowledge and tools for working with policymakers in low- and middle-income countries (LMICs) as they adapt and adopt national policies for appropriate use of antimicrobials. Key questions this research will address include: a. Who are the key policy actors to engage for effective implementation of interventions and policies concerning appropriate antimicrobial use? How are these actors currently, and potentially, connected?b. How are the selected policy options socially constructed and how do social constructions reinforce or weaken support or opposition for the selected policies?c. What other motivations, power relations and contextual factors drive the selection of specific policies?d. How do these differ among different groups of policymakers identified under objective 1 (e.g. animal health versus human health or political affiliation)?e. Based on analysis of the questions above, how do policies for appropriate use need to be presented and framed to ensure that essential groups of policy actors engage with and respond to these effectively? This project focuses on the drivers of policy actor behaviour in one high risk AMR country in South Asia - Pakistan. With a population of 185 million, it is possibly the largest country without a national policy or guideline on AMR (Horton 2013). A key consideration for appropriate use interventions is care provision through the for-profit and informal health sector. This issue is particularly critical in South Asia where 80% of patients seek care within the poorly regulated private or informal sector (Private Sector for Health, 2016), and Pakistan provides an ideal case study to investigate this as 78% of the population pay out-of-pocket and the private sector provides 75% of health services (Nishtar 2013). The project will then follow a step wise approach to triangulate findings at national level, at regional level in South Asia and with global policymakers. Research outputs include guides for policymakers working on AMR, a research methodology, as well as scientific outputs and papers.Research will be begin by comprehensively mapping the range of policy actors involved in policy processes relating to appropriate use of AMs, across the One Health spectrum including private and public sector actors. Using the list of policy actors generated by the mapping exercise, we will purposively select policy actors for in-depth interviews (IDI). As part of the IDI process, actors will be asked questions to explore their perceptions about AMR and AM use and to then rank the five policy options while talking through their rationale using a 'thinking aloud' methodological approach. Research will be conducted by an interdisciplinary team of social and animal scientists from the London School of Hygiene and Tropical Medicine, the Aga Khan University in Pakistan, the National University of Singapore and the Royal Veterinary College in London. Research will in addition benefit from advice and oversight of an academic and an impact advisory panel to ensure maximum impact on policy and future research on AMR.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/s12960-020-0452-7
发表时间:
2020-02-11
期刊:
HUMAN RESOURCES FOR HEALTH
影响因子:
4.5
作者:
[Khan, Mishal S., Bory, Sothavireak, Saphonn, Vonthanak]
通讯作者:
Saphonn, Vonthanak
DOI:
10.1136/bmj.j3505
发表时间:
2017-07-24
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
[Hanefeld J, Khan M, Tomson G, Smith R]
通讯作者:
Smith R
DOI:
10.2471/blt.17.198614
发表时间:
2018-03-01
期刊:
Bulletin of the World Health Organization
影响因子:
11.1
作者:
[Hasan R, Shakoor S, Hanefeld J, Khan M]
通讯作者:
Khan M
DOI:
10.1136/bmjgh-2022-008596
发表时间:
2022-05
期刊:
BMJ GLOBAL HEALTH
影响因子:
8.1
作者:
[Khan, Mishal, Rahman-Shepherd, Afifah, Bory, Sothavireak, Chhorn, Sophea, Durrance-Bagale, Anna, Hasan, Rumina, Heng, Sotheara, Phou, Socheata, Prien, Chanra, Probandari, Ari, Saphonn, Vonthanak, Suy, Sovanthida, Wiseman, Virginia, Wulandari, Luh Putu Lila, Hanefeld, Johanna]
通讯作者:
Hanefeld, Johanna
Migration, gender and health system responses in South Africa: A focus on the movement of healthcare users and workers
-
批准号:MR/S013601/1
-
项目类别:Research Grant
-
资助金额:$88.47万
-
财政年份:2019
-
负责人:Johanna Hanefeld
-
依托单位:
Strengthening health system promotion of maternal and child health through medical travel
-
批准号:MR/M002160/1
-
项目类别:Research Grant
-
资助金额:$11.3万
-
财政年份:2015
-
负责人:Johanna Hanefeld
-
依托单位:
国内基金
海外基金
登录
查看更多内容
复合菌剂在高DO下的好氧反硝化脱氮机制及工艺调控研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周月明
-
依托单位:
内生真菌DO14多糖PPF30调控铁皮石斛葡甘聚糖生物合成的机制
-
批准号:LZ23H280001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:吴令上
-
依托单位:
基于捕获“Do not eat me”信号的肺癌异质性分子功能可视化及机理研究
-
批准号:92259102
-
项目类别:重大研究计划
-
资助金额:60.00万元
-
批准年份:2022
-
负责人:许川
-
依托单位:
基于达文波特星形酵母Do18强化发酵的糟带鱼生物胺生物调控机制
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:涂传海
-
依托单位:
基于PO-DGT原理的沉积物微界面pH-DO-磷-重金属的精细化同步成像技术研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:韩超
-
依托单位:
CD38/cADPR信号通路异常促逼尿肌过度活动(DO)发生的分子机制及干预措施研究
-
批准号:81770762
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:郑霁
-
依托单位:
USP2介导RagA去泛素化稳定肿瘤细胞“Do not eat me”信号的机制研究
-
批准号:81773040
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2017
-
负责人:金国祥
-
依托单位:
抑制骨细胞来源Sclerostin蛋白对颌面部DO成骨的协同促进作用
-
批准号:81771104
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2017
-
负责人:钱玉芬
-
依托单位:
内生真菌DO14促铁皮石斛多糖成分积累的作用机制
-
批准号:31600259
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:吴令上
-
依托单位:
末次冰期东亚季风DO事件的定年、转型及亚旋回研究
-
批准号:40702026
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2007
-
负责人:陈仕涛
-
依托单位: